NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market
Holding NRBO?
Track your performance easily

NeuroBo Pharmaceuticals (NRBO) Stock Investors

324 Followers
Based on 760,547 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NRBO
On average, investors allocate 0.00% of their portfolios to NRBO
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 760,547 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NRBO

2.5%
Last 7
Days
1.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NRBO, out of 760,547 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NRBO Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,574 investors who made their portfolios public
The table shows changes in NRBO in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NRBO Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Viking Therapeutics
5.14%
-0.20%
+1.43%
7.39B
Healthcare
DraftKings
5.48%
-0.55%
-2.33%
32.95B
Consumer Cyclical
JD
5.18%
+0.23%
+6.83%
65.88B
Consumer Cyclical
Plug Power
5.15%
-0.78%
-3.40%
1.81B
Industrials
Blink Charging Co
5.40%
-1.45%
-4.73%
193.20M
Industrials
Enphase Energy
4.95%
-1.48%
-2.62%
14.11B
Technology
XPeng, Inc. ADR
5.57%
+0.15%
-2.06%
10.96B
Consumer Cyclical
RTX
4.25%
+0.11%
+1.30%
164.28B
Industrials
CVS Health
4.18%
-0.93%
-0.92%
82.90B
Healthcare
Marathon Digital Holdings
5.26%
-0.72%
-1.89%
4.66B
Financial
Based on the activity of 760,547 active portfolios
Open your Smart Portfolio

NRBO Investor Analysis

NRBO investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.9%
of NRBO holders
are under 35
Average Segment Performance
Average P/E Ratio22.25
Beta8.29
Dividend Yield3.40%
NRBO investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.1%
of NRBO holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.30
Beta14.63
Dividend Yield3.12%
NRBO investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
31.0%
of NRBO holders
are over 55
Average Segment Performance
Average P/E Ratio21.78
Beta7.19
Dividend Yield3.21%
Overview of age group and performance of NRBO stock investors
See who invests in NRBO according to age group and performance.

FAQ

How many retail Investors hold NRBO?
<0.1% of TipRanks' retail investors hold NRBO in their portfolios.
    What is NRBO Investor Sentiment?
    NRBO’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of NRBO in the last 7 days?
      ▲ 2.5% of TipRanks' retail investors changed their holding of NRBO in the last 7 days.
        What percentage of retail investors changed their holding of NRBO in the last 30 days?
        ▼ 1.8% of TipRanks' retail investors changed their holding of NRBO in the last 30 days.
          What is the average age of retail investors who hold NRBO?
          The average age of NRBO Holders is between 35–55.
            What other stocks have NRBO investors also bought?
            NRBO Investors also bought VKTX, DKNG, JD, PLUG, BLNK, ENPH, XPEV, RTX, CVS, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              AAgilent
              BAXBaxter International
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis